Cytodyn Inc (CYDY)

[BlackDoggie]

I haven't seen those results before either, pretty sure that's updated from any previous releases. While we'd all love to see the N higher at this point, we don't know exactly when the data points were taken for this abstract, and the endpoint results are (unsurprisingly) impressive. And while the slow enrollment has been annoying, what's kept me up at night (so to speak) is the possibility that the data doesn't come back as strong as expected once the enrollment is complete. This data appears to be as strong as expected, maybe better.

That's good enough for me to sit back and average down.